Skip to main content
Menu
Language
Appearance
LAB BENCH

From extracted DNA to a called variant

The consumables that carry a hereditary-cancer sample across the bench — extraction chemistry, library preparation, and the flow cell itself. Educational explainers for the curious; not laboratory protocols, and never medical advice.

≥30×
minimum per-base coverage typically sought for germline panels
Scientific Reports / PMC
>99%
of target bases above 30× on validated cancer panels (vs ~94% for WES)
PMC7189534
50–500 bp
fragment range produced by tagmentation in library prep
NGS method literature
26–35B
single reads per NovaSeq X flow cell
Illumina specifications

Swab to sequencer: the bench workflow

Every hereditary-cancer result begins as a tube of cells and ends as a base-called read. Four consumable-heavy stages sit between. Each links to the products and the science behind it.

  1. 01

    1. Nucleic-acid extraction

    Lysis, binding, wash, and elution recover genomic DNA from saliva, buccal cells, or blood. Magnetic-bead systems (e.g. Promega Maxwell, MagPurix) yield clean, high-molecular-weight DNA quantified by fluorometry (Qubit) before anything downstream proceeds.

  2. 02

    2. Library preparation

    DNA is fragmented (sonication or tagmentation into ~50–500 bp pieces), end-repaired, and ligated to sequencing adapters. For panels, biotinylated hybrid-capture probes enrich only the genes of interest — BRCA1, BRCA2, PALB2, TP53 and the rest of the panel.

  3. 03

    3. Quantification & pooling

    Libraries are normalised by qPCR or fluorometric assay so each sample contributes evenly to the pool. Accurate molarity here is what protects per-sample read depth later — under-loaded libraries fall below the 30× floor.

  4. 04

    4. Sequencing

    The pooled library is loaded onto a flow cell. Clusters are amplified in situ and sequenced by synthesis; raw reads are then aligned and variants called against a reference, ready for ACMG classification.

Reading depth by application

How much coverage a region needs depends on what you are asking of it. Germline questions tolerate less depth than somatic ones because the expected variant fraction is higher and more predictable.

ApplicationTypical depthWhySource
Germline panel (e.g. BRCA1/BRCA2)≥30×Heterozygous variants sit near a 50% allele fraction and are reliably called at modest depthPMC / Scientific Reports
Whole-genome germline~30–35×Standard for germline SNV/indel/CNV detection across the genomeManufacturer guidance
Somatic / tumour variants~100×+Low-fraction mosaic and subclonal variants demand far deeper readsPanel literature
Whole-exome (comparison)~94% bases ≥30×Broader target, less uniform capture than a focused panelPMC7189534

Table 1. Indicative per-base coverage targets reported in the panel-sequencing literature.

NovaSeq output, illustrated

Flow-cell capacity has scaled by an order of magnitude across one product generation. More reads per run means more samples multiplexed without sacrificing the per-sample depth floor. Values are approximate single-read maxima from manufacturer specifications.

NovaSeq 6000 (SP–S4 range)2.5 B reads

up to ~2.5B paired-end reads per lane; ~20B per run

NovaSeq X — 1.5B flow cell1.5 B reads

smaller-batch runs

NovaSeq X — 10B flow cell10 B reads

mid throughput

NovaSeq X — 25B flow cell26 B reads

26–35B single reads per flow cell

Bench glossary

A few terms that recur across the four spokes.

Tagmentation
A transposase-driven reaction that fragments DNA into ~50–500 bp pieces and ligates adapters in a single step, compressing two library-prep stages into one.
Hybrid capture
Target enrichment using biotinylated probes that bind chosen regions (the panel genes), so sequencing reads are spent only where they are needed rather than across the whole genome.
Coverage (depth)
The number of independent reads spanning a given base. A 30× target means most bases are read at least thirty times, giving confidence in each genotype call.
Mean genomic coverage
The average read depth across the targeted footprint; validated hereditary-cancer assays have reported >99% sensitivity for germline SNVs, indels, and CNVs at ~35× mean coverage.
References
  1. [1]Scientific Reports 2016. A comprehensive custom panel design for routine hereditary cancer testing — Scientific Reports (srep39348). Notes ≥30× minimum coverage across regions of interest.
  2. [2]PMC 2020. Development and validation of a next-generation-sequencing-based 35-gene hereditary cancer panel. >99% of bases ≥30× vs ~94% for WES.
  3. [3]Illumina specifications. NovaSeq X Series specifications — 26–35 billion single reads per flow cell; 1.5B / 10B / 25B flow-cell options.
  4. [4]Illumina specifications. NovaSeq 6000 specifications — SP/S1/S2/S4 flow cells; up to ~20B paired-end reads per run.

The bench is only half the story

Sample collection and shipping decide what reaches the lab in the first place. See how a swab is preserved and transported before extraction even begins.